| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/27/2007 | WO2007107311A2 Organic sulphinic acid derivatives |
| 09/27/2007 | WO2007085356A3 Insecticidal (heteroarylalkyl)alkane thio and oxo amine derivatives |
| 09/27/2007 | US20070225503 Ambient-temperature molten salts and process for producing the same |
| 09/27/2007 | US20070225373 Zn2Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase |
| 09/27/2007 | US20070225365 Cetp Inhibitors |
| 09/27/2007 | US20070225363 Methods and Agents for Inhibiting Dynamin-Dependent Endocytosis |
| 09/27/2007 | US20070225340 Phenyl Compounds And Their Use In The Treatment Of Conditions Mediated By The Action Of Pge2 At The Ep1 Receptor |
| 09/27/2007 | US20070225336 Anthropodicidal anthranilamides |
| 09/27/2007 | US20070225329 Aryl aniline beta2 adrenergic receptor agonists |
| 09/27/2007 | US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 09/27/2007 | US20070225292 Therapeutic Compounds: Pyridine as Scaffold |
| 09/27/2007 | US20070225229 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 09/27/2007 | US20070224447 Organometallic Complex, Luminescent Solid, Organic el Element and Organic el Display |
| 09/27/2007 | CA2642452A1 Process for preparing 1-halo-2,7-naphthyridinyl derivatives |
| 09/26/2007 | EP1837330A1 Benzamide inhibitors of the P2X7 receptor |
| 09/26/2007 | EP1836189A1 Novel pyridine compounds |
| 09/26/2007 | EP1836178A1 Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 09/26/2007 | EP1836171A1 6-(2,3,4,5-tetrahydro-1h-benzo[d]azepin-7-yloxy)-nicotamide derivatives as radiolabelled ligands |
| 09/26/2007 | EP1836170A1 N-((2z)-2-((4-hydroxyphenyl)imino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 |
| 09/26/2007 | EP1836169A2 Compositions and methods of treating cell proliferation disorders |
| 09/26/2007 | EP1836158A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 09/26/2007 | EP1836149A1 Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 09/26/2007 | EP1699752B1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1302461B1 Tnf-alpha production inhibitors |
| 09/26/2007 | EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP1154998B1 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy |
| 09/26/2007 | CN101044436A Charge control agent and related technique |
| 09/26/2007 | CN101044125A Heterocyclic compounds and methods of use |
| 09/26/2007 | CN101044112A O-aminophenol derivatives and colorants containing these compounds |
| 09/26/2007 | CN101041669A Non nucleoside reverse transcriptase inhibitors |
| 09/26/2007 | CN100339367C Process for the preparation of 2-aminomethylpyridine derivative |
| 09/26/2007 | CN100339360C Process for producing aromatic nitrile compound |
| 09/25/2007 | US7273940 Complex with iron, cobalt; polymerization of alpha-olefins, cyclic olefin |
| 09/25/2007 | US7273938 Reacting a 2,5-dibromopyridine with an alkyllithium and a enolizable aldehyde or ketone to form a 2-(optionally disubstituted hydroxymethyl)-5-bromopyridine while quenching with a proton donor |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273877 5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | CA2415551C Aniline derivatives |
| 09/25/2007 | CA2323477C Polymerization catalyst comprising a pyridine-bis(imine)complex |
| 09/25/2007 | CA2294278C Chalcones having antiproliferative activity |
| 09/20/2007 | WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | WO2007104783A2 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators |
| 09/20/2007 | WO2007104361A1 Nanofibers from functionalized organic molecules |
| 09/20/2007 | US20070219274 (R)-Chiral Halogenated Substituted Fused Heterocyclic Amino Compounds Useful for Inhibiting Cholesterol Ester Transfer Protein Activity |
| 09/20/2007 | US20070219255 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 09/20/2007 | US20070219254 Therapeutic Compounds: Pyridine N-Oxide Scaffold |
| 09/20/2007 | US20070219233 Substituted Indoles and Their Use as Integrin Antagonists |
| 09/20/2007 | US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives |
| 09/20/2007 | DE102005038803A1 Verfahren zur Herstellung von 5-Aryl-Nicotinsäureamiden Process for the preparation of 5-aryl-Nicotinsäureamiden |
| 09/20/2007 | CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/19/2007 | EP1834956A1 Metal complex compound and organic electroluminescent element using the same |
| 09/19/2007 | EP1833834A1 New compounds |
| 09/19/2007 | EP1833796A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 09/19/2007 | EP1833795A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 09/19/2007 | EP1833794A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 09/19/2007 | EP1833793A1 Process for the preparation of a 2-ethylaminopyridine derivative |
| 09/19/2007 | EP1740544B1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides |
| 09/19/2007 | EP1622867B1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | EP1436263B1 A process for preparing beta-ketoester compound |
| 09/19/2007 | EP1406605B1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 09/19/2007 | EP1334962B1 Process for the preparation of acylphenylalanines |
| 09/19/2007 | EP1198456B1 Potassium channel openers |
| 09/19/2007 | EP1192134B1 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol |
| 09/19/2007 | CN101039938A Diphenyl substituted alkanes as flap inhibitors |
| 09/19/2007 | CN101039915A Phenoxy benzamide compounds with utility in the treatment of type 2 diabetes and obesity |
| 09/19/2007 | CN101039913A Method for producing high-purity quaternary ammonium compounds |
| 09/19/2007 | CN101039912A Pyridine derivatives and the preparation and the therapeutic use thereof |
| 09/19/2007 | CN101039905A New histone deacetylases inhibitors |
| 09/19/2007 | CN101039902A Aminoalcohol derivatives |
| 09/19/2007 | CN101039901A Process for making phenoxy benzamide compounds |
| 09/19/2007 | CN101037410A Triphenylamine derivative double-photon optical storage material and preparation method thereof |
| 09/19/2007 | CN101036648A Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 09/19/2007 | CN100338055C Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 09/19/2007 | CN100338047C Process for the preparation of pyrazolopyrimidin ones |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100337545C Liquid formulations for dernal application in treatment of parasitic insects in animals |
| 09/18/2007 | USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 09/18/2007 | US7271270 High affinity small molecule C5a receptor modulators |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action |
| 09/18/2007 | US7271196 CETP activity inhibitors |
| 09/18/2007 | US7271184 For controlling parasites on warm-blooded animals; veterinary medicine |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/18/2007 | US7270893 Organic electroluminescent element and display |
| 09/18/2007 | CA2416229C Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 09/18/2007 | CA2411957C Novel process for the preparation of pyrazolopyrimidinones |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2316360C Process for production of donepezil derivative |
| 09/18/2007 | CA2275764C Process for the preparation of heteroaryl-phenylalanines |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them |
| 09/13/2007 | WO2007103719A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |